Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
2.
J Cataract Refract Surg ; 40(8): 1337-40, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25088634

RESUMEN

PURPOSE: To evaluate the safety of a new high-intensity corneal collagen crosslinking (CXL) treatment protocol for keratoconus. SETTING: Vardinoyiannion Eye Institute of Crete, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece. DESIGN: Prospective interventional case series. METHODS: Patients with progressive keratoconus had CXL using a new treatment protocol with 9 mW/cm(2) irradiance for duration of 10 minutes. The rate of reepithelialization, endothelial cell density (ECD), corrected distance visual acuity (CDVA), and steep and flat keratometry (K) values were evaluated preoperatively and 3 months postoperatively. RESULTS: Nine patients (10 eyes) were enrolled. No intraoperative or early postoperative complications were observed in any patient. The ECD did not change significantly 3 months postoperatively (P=.169). The CDVA improved from 0.19 logMAR ± 0.20 (SD) preoperatively to 0.10 ± 0.16 logMAR 3 months postoperatively; however, the improvement did not attain significance (P=.141). No eye lost lines of CDVA. The mean steep K readings decreased significantly from 48.04 ± 2.57 diopters (D) preoperatively to 46.51 ± 2.81 D 3 months postoperatively (P=.047); the mean flat K readings did not change significantly postoperatively (P=.285). CONCLUSIONS: Corneal collagen crosslinking at 9 mW/cm(2) irradiance for 10 minutes did not cause significant changes in ECD or intraoperative or early postoperative complications. None patient lost a line of CDVA 3 months after the procedure. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.


Asunto(s)
Colágeno/metabolismo , Sustancia Propia/metabolismo , Reactivos de Enlaces Cruzados/uso terapéutico , Queratocono/tratamiento farmacológico , Fármacos Fotosensibilizantes/uso terapéutico , Adolescente , Adulto , Recuento de Células , Reactivos de Enlaces Cruzados/efectos adversos , Endotelio Corneal/patología , Femenino , Humanos , Complicaciones Intraoperatorias , Queratocono/metabolismo , Queratocono/fisiopatología , Masculino , Microscopía Confocal , Fármacos Fotosensibilizantes/efectos adversos , Complicaciones Posoperatorias , Estudios Prospectivos , Riboflavina/efectos adversos , Riboflavina/uso terapéutico , Rayos Ultravioleta , Agudeza Visual/fisiología , Adulto Joven
3.
J Cataract Refract Surg ; 40(2): 224-31, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24373376

RESUMEN

PURPOSE: To compare the visual and refractive outcomes and the corneal structural changes in myopic patients after surface refractive treatments (ie, photorefractive keratectomy [PRK] with adjuvant mitomycin-C [MMC] and epithelial laser in situ keratomileusis [epi-LASIK]). SETTING: University of Crete, Heraklion, Crete, Greece. DESIGN: Prospective comparative case series. METHODS: One eye of consecutive myopic patients was randomly assigned to PRK-MMC, and the fellow eye was treated with epi-LASIK. Visual and refractive outcomes and corneal confocal microscopy findings were evaluated. All patients were examined preoperatively and 1, 3, 6, 12, and 24 months postoperatively. RESULTS: Twenty-six eyes (13 patients) were included. The mean follow-up was 2.47 years ± 0.35 (SD) (range 1.64 to 2.93 years). In the PRK-MMC group, the mean preoperative spherical equivalent refraction was -3.84 ± 1.59 diopters (D) (range -1.5 to -8.7 D) and -0.21 ± 0.44 D (range -0.5 to 1.0 D) at the last follow-up and in the epi-LASIK group, -3.91 ± 1.48 D (range -1.5 to -8.5 D) and -0.18 ± 0.36 (range +0.5 to -0.5 D), respectively. Qualitative analysis of the subepithelial nerve plexus, haze development, and keratocyte distribution were similar in the 2 groups. There was no statistically significant difference in endothelial cell density between the groups throughout the follow-up (P>.05). CONCLUSION: Epithelial LASIK and PRK-MMC gave similar visual, refractive, and corneal structural outcomes in patients with myopia for up to 2 years postoperatively. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.


Asunto(s)
Alquilantes/administración & dosificación , Córnea/patología , Queratomileusis por Láser In Situ , Láseres de Excímeros/uso terapéutico , Mitomicina/administración & dosificación , Miopía/cirugía , Queratectomía Fotorrefractiva , Adulto , Recuento de Células , Terapia Combinada , Córnea/inervación , Queratocitos de la Córnea/patología , Endotelio Corneal/patología , Femenino , Estudios de Seguimiento , Humanos , Masculino , Microscopía Confocal , Miopía/patología , Nervio Oftálmico/patología , Estudios Prospectivos , Refracción Ocular/fisiología , Resultado del Tratamiento , Agudeza Visual/fisiología , Adulto Joven
4.
Am J Ophthalmol ; 157(1): 110-115.e1, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24200235

RESUMEN

PURPOSE: To evaluate and compare the depth of the corneal stromal demarcation line after corneal collagen cross-linking (CXL) using 2 different methods: confocal microscopy and anterior segment optical coherence tomography (AS OCT). DESIGN: Prospective, comparative, interventional case series. METHODS: Seventeen patients (18 eyes) with progressive keratoconus were enrolled. All patients underwent uneventful CXL treatment according to the Dresden protocol. One month after surgery, corneal stromal demarcation line depth was measured in all patients by 2 independent observers using confocal microscopy and AS OCT. RESULTS: Mean corneal stromal demarcation line depth measured using confocal microscopy by the first observer was 306.22 ± 51.54 µm (range, 245 to 417 µm) and that measured by the second observer was 303.5 ± 46.98 µm (range, 240 to 390 µm). The same measurements using AS OCT were 300.67 ± 41.56 µm (range, 240 to 385 µm) and 295.72 ± 41.01 µm (range, 228 to 380 µm) for the first and second observer, respectively. Pairwise comparisons did not reveal any statistically significant difference between confocal microscopy and AS OCT measurements for both observers (P = .3219 for the first observer and P = .1731 for the second observer). CONCLUSIONS: Both confocal microscopy and AS OCT have similar results in evaluating the depth of the corneal stromal demarcation line after CXL.


Asunto(s)
Colágeno/metabolismo , Sustancia Propia/patología , Reactivos de Enlaces Cruzados/uso terapéutico , Queratocono/diagnóstico , Microscopía Confocal , Tomografía de Coherencia Óptica , Adulto , Sustancia Propia/metabolismo , Femenino , Humanos , Complicaciones Intraoperatorias , Queratocono/tratamiento farmacológico , Queratocono/metabolismo , Masculino , Persona de Mediana Edad , Fármacos Fotosensibilizantes/uso terapéutico , Complicaciones Posoperatorias , Estudios Prospectivos , Riboflavina/uso terapéutico , Rayos Ultravioleta , Adulto Joven
5.
Ophthalmology ; 120(5): 917-22, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23337554

RESUMEN

PURPOSE: To evaluate the effect of corneal collagen cross-linking (CXL) on corneal innervation, corneal sensitivity, and tear function in patients with keratoconus. DESIGN: Prospective, interventional case series. PARTICIPANTS: Twenty-four patients with bilateral keratoconus (30 eyes) who presented to the Institute of Vision and Optics, University of Crete, from May 2008 to October 2008. METHODS: Patients underwent CXL. Confocal microscopic analysis of corneal sub-basal nerve plexus (total nerve length per image), corneal sensitivity (assessed with the Cochet-Bonnet esthesiometer), basic tear secretion (assessed with Schirmer's I test with anesthesia), and tear film stability (evaluated by means of tear film break-up time [TFBUT]) were assessed preoperatively and at 1, 3, 6, 9, 12, 18, and 24 months postoperatively. MAIN OUTCOME MEASURES: Comparisons between preoperative and each postoperative value of total nerve length per image, corneal sensitivity, Schirmer's I test results, and TFBUT. RESULTS: Total nerve length per image and corneal sensitivity were significantly decreased until postoperative month 6 (for both parameters: P<0.05 paired-samples t test at 1, 3, and 6 months postoperatively). Total nerve length per image tended to increase up to 2 years postoperatively, when it reached the preoperative level, but differences with the preoperative values after the sixth post-CXL month were insignificant. The results of Schirmer's I test and TFBUT had no statistically significant difference at any time point. CONCLUSIONS: A transient decrease in corneal innervation and corneal sensitivity can be observed up to 6 months after CXL. No significant effect of CXL could be detected on basic tear secretion and tear film stability in our group of patients. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.


Asunto(s)
Córnea/inervación , Queratocono/terapia , Fotoquimioterapia/efectos adversos , Lágrimas/fisiología , Terapia Ultravioleta/efectos adversos , Adulto , Córnea/efectos de los fármacos , Córnea/metabolismo , Córnea/efectos de la radiación , Femenino , Humanos , Queratocono/fisiopatología , Masculino , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/uso terapéutico , Estudios Prospectivos , Riboflavina/uso terapéutico , Adulto Joven
6.
Ophthalmologica ; 228(1): 53-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22488127

RESUMEN

BACKGROUND/AIMS: To evaluate the alterations of mean foveal thickness (MFT) and visual acuity (VA) outcomes after uncomplicated cataract surgery in different groups of patients. METHODS: This study included eyes of consecutive patients who underwent cataract surgery between November 2007 and June 2009. The patients included in the study were divided into 4 groups, as follows: history-free patients, patients with diabetes mellitus without macular involvement at baseline, patients with glaucoma, and patients with epiretinal membrane (ERM). Preoperatively and at 1, 3 and 6 months postoperatively, patients were evaluated for MFT by optical coherence tomography at the central 1-mm macular zone and for logarithm of the minimum angle of resolution best spectacle-corrected VA (BSCVA). RESULTS: A total of 202 eyes were included in the study. MFT values demonstrated a statistically significant increase (p < 0.01) after cataract surgery in all groups at the first and third postoperative month. The history-free (p = 0.09) and glaucoma (p = 0.19) groups did not demonstrate a statistically significant difference in MFT values between the preoperative and 6-month measurements. MFT values 6 months after cataract surgery in the diabetes and ERM groups remained significantly higher (p < 0.01). Despite these findings, VA increased significantly (p < 0.01) in all groups at all postoperative follow-ups. CONCLUSIONS: MFT values increased significantly in all groups at the first and third months after cataract surgery. At 6 months, MFT values returned to preoperative levels in the history-free and glaucoma patients, while they remained significantly higher in the diabetic and ERM patients. Despite these macular alterations, BSCVA improved significantly after cataract surgery in all groups at all postoperative follow-ups.


Asunto(s)
Fóvea Central/patología , Implantación de Lentes Intraoculares , Facoemulsificación , Complicaciones Posoperatorias , Enfermedades de la Retina/etiología , Adulto , Anciano , Anciano de 80 o más Años , Diabetes Mellitus/etiología , Membrana Epirretinal/etiología , Femenino , Glaucoma/etiología , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Enfermedades de la Retina/diagnóstico , Tomografía de Coherencia Óptica , Agudeza Visual/fisiología
7.
Eur J Ophthalmol ; 19(5): 738-42, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19787591

RESUMEN

PURPOSE: To evaluate mitomycin C (MMC) aqueous humor concentration after photorefractive keratectomy (PRK). METHODS: In this experimental study, twenty-four eyes of 12 male pigmented rabbits were divided into 4 groups and studied at the Institute of Vision and Optics, Department of Medicine, University of Crete, Greece. Eyes in groups 1 and 2 underwent PRK to correct -5 diopters (D) in a 6-mm optical zone, while sponges soaked with 0.02% MMC were applied on the exposed corneal stroma for 60 and 120 seconds, respectively. Similarly, eyes in groups 3 and 4 underwent PRK to correct -10 D in a 6-mm optical zone, while sponges soaked with 0.02% MMC were applied on the exposed corneal stroma for 60 and 120 seconds, respectively. Aqueous humor was extracted from all rabbit eyes 10 minutes after MMC application and high-performance liquid chromatography was performed immediately to detect and quantify MMC levels. RESULTS: The mean aqueous humor concentration of MMC was 0.23+/-0.03 microg/mL, 0.39+/-0.05 microg/mL, 0.28+/-0.04 microg/mL, and 0.52+/-0.16 microg/mL in groups 1, 2, 3, and 4, respectively. The effect of application time and correction on aqueous humor MMC concentration was significant (p<0.0001 and p=0.019), while the exposure time had a greater impact on aqueous humor MMC concentration when compared with the attempted correction. CONCLUSIONS: Both exposure time of MMC on the corneal stroma and the attempted correction was correlated with MMC aqueous humor concentrations.


Asunto(s)
Alquilantes/farmacocinética , Humor Acuoso/metabolismo , Mitomicina/farmacocinética , Miopía/cirugía , Queratectomía Fotorrefractiva , Administración Tópica , Alquilantes/administración & dosificación , Animales , Cromatografía Líquida de Alta Presión , Sustancia Propia/efectos de los fármacos , Modelos Animales de Enfermedad , Masculino , Mitomicina/administración & dosificación , Conejos , Refracción Ocular , Factores de Tiempo
8.
Am J Ophthalmol ; 147(5): 774-8, 778.e1, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19200532

RESUMEN

PURPOSE: To investigate corneal tissue alterations after corneal collagen cross-linking in patients with post laser in situ keratosmileusis (LASIK) keratectasia and keratoconus. DESIGN: Prospective comparative case series. METHODS: Five patients (5 eyes) with iatrogenic keratectasia after LASIK and 5 patients (5 eyes) with progressive keratoconus were included. All eyes underwent corneal cross-linking and were assessed by corneal in vivo confocal microscopy. Three normal/healthy and 3 post-LASIK without ectasia corneas were also examined as controls. RESULTS: All corneas revealed normal epithelial thickness before and after surgery. Images of both keratoconic and post-LASIK corneal ectasia eyes revealed similar morphologic alterations. The subepithelial nerve plexus was absent immediately after treatment; regeneration of nerves was evident after the third postoperative month. Keratocytes were absent from the anterior 300 mum of the stroma in the first 3 months while the posterior stromal density of keratocytes was increased. Corneal collagen fibers in the anterior stroma were distributed unevenly in a net-like formation. Full-thickness keratocyte repopulation in the anterior and mid-corneal stroma was detected 6 months after treatment. The corneal endothelium did not undergo any significant changes, since the cell density and hexagonality was not found altered during the follow-up period. CONCLUSIONS: Keratocyte nuclei apoptosis in the anterior and intermediate corneal stroma along with collagen alterations were observed during the first 3 postcorneal cross-linking months. Gradual keratocyte repopulation was demonstrated over the following months. Corneal alterations after corneal cross-linking were similar in both keratoconic and post-LASIK corneal ectasia eyes.


Asunto(s)
Colágeno/metabolismo , Sustancia Propia/patología , Queratocono/diagnóstico , Queratomileusis por Láser In Situ/efectos adversos , Microscopía Confocal , Fotoquimioterapia , Complicaciones Posoperatorias , Sustancia Propia/metabolismo , Dilatación Patológica/diagnóstico , Dilatación Patológica/tratamiento farmacológico , Dilatación Patológica/etiología , Dilatación Patológica/metabolismo , Estudios de Seguimiento , Humanos , Enfermedad Iatrogénica , Queratocono/tratamiento farmacológico , Queratocono/etiología , Queratocono/metabolismo , Fármacos Fotosensibilizantes/uso terapéutico , Estudios Prospectivos , Riboflavina/uso terapéutico , Rayos Ultravioleta
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA